• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRAF突变阳性的向毛囊性转移性黑色素瘤。

BRAF mutation-positive folliculotropic metastatic melanoma.

作者信息

Brick Katherine E, Halling Kevin C, Khan Yulia K, Peters Margot S

机构信息

Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Am J Dermatopathol. 2013 Jul;35(5):609-12. doi: 10.1097/DAD.0b013e31827a0bfb.

DOI:10.1097/DAD.0b013e31827a0bfb
PMID:23715079
Abstract

Primary cutaneous folliculotropic melanoma has been described rarely, and there are even fewer published cases of folliculotropic metastases. We report a 54-year-old man with history of primary cutaneous melanoma of the right posterior shoulder, Breslow depth of 3.4 mm, with one positive sentinel lymph node, negative full axillary dissection, and no extranodal metastases at initial staging. Three years later, he presented with an asymptomatic isolated 2-mm blue-black papule on the scalp and was found to have widespread metastatic melanoma involving lymph nodes, liver, adrenal glands, subcutaneous tissue, skeleton, and lung. Histopathologic examination of the scalp lesion demonstrated a tumor nodule composed of sheets and nests of large round to polygonal cells centered about a hair follicle and within follicular epithelium. BRAF V600E gene mutation was documented in this lesion, and the patient received vemurafenib, with dramatic improvement noted on positron emission tomography scan after 2 months of treatment, soon followed by development of extensive metastases, including to brain. Although BRAF mutations have been found in primary and metastatic melanomas of the skin, and in melanoma metastases of extracutaneous sites, to our knowledge, this is the first case of a BRAF mutation documented in folliculotropic metastatic melanoma.

摘要

原发性皮肤毛囊性黑色素瘤鲜有报道,毛囊性转移的病例更是少见。我们报告了一名54岁男性,有右后肩部原发性皮肤黑色素瘤病史,Breslow厚度为3.4mm,前哨淋巴结1枚阳性,腋窝清扫阴性,初始分期无结外转移。三年后,他头皮上出现一个无症状的孤立2mm蓝黑色丘疹,发现有广泛转移性黑色素瘤,累及淋巴结、肝脏、肾上腺、皮下组织、骨骼和肺。头皮病变的组织病理学检查显示一个肿瘤结节,由围绕毛囊及在毛囊上皮内的大片和巢状大圆形至多边形细胞组成。该病变检测到BRAF V600E基因突变,患者接受维莫非尼治疗,治疗2个月后正电子发射断层扫描显示显著改善,但随后很快出现广泛转移,包括脑转移。虽然在皮肤原发性和转移性黑色素瘤以及皮肤外部位的黑色素瘤转移中都发现了BRAF突变,但据我们所知,这是第一例在毛囊性转移性黑色素瘤中记录到BRAF突变的病例。

相似文献

1
BRAF mutation-positive folliculotropic metastatic melanoma.BRAF突变阳性的向毛囊性转移性黑色素瘤。
Am J Dermatopathol. 2013 Jul;35(5):609-12. doi: 10.1097/DAD.0b013e31827a0bfb.
2
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.BRAF V600E突变状态在原发性皮肤黑色素瘤患者前哨淋巴结包膜痣中的临床意义
Hum Pathol. 2017 Jan;59:48-54. doi: 10.1016/j.humpath.2016.09.010. Epub 2016 Sep 22.
3
Lymph node metastases of melanoma: challenges for BRAF mutation detection.黑色素瘤的淋巴结转移:BRAF 突变检测面临的挑战
Hum Pathol. 2015 Jan;46(1):113-9. doi: 10.1016/j.humpath.2014.09.014. Epub 2014 Oct 7.
4
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.维莫非尼治疗 BRAF(V600) 突变转移性黑色素瘤患者:一项开放性、多中心、安全性研究。
Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.
5
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.维莫非尼治疗伴有症状性脑转移的 BRAF(V600) 突变阳性黑色素瘤患者:一项开放标签的初步研究的最终结果。
Eur J Cancer. 2014 Feb;50(3):611-21. doi: 10.1016/j.ejca.2013.11.002. Epub 2013 Nov 29.
6
Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.致癌 BRAF 在转移性黑色素瘤中的预后和临床病理关联。
J Clin Oncol. 2011 Apr 1;29(10):1239-46. doi: 10.1200/JCO.2010.32.4327. Epub 2011 Feb 22.
7
Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.原发性黑色素瘤及配对转移灶中BRAFV600突变的等位基因频率及其与转移性黑色素瘤BRAF抑制剂治疗的相关性。
Oncotarget. 2015 Nov 10;6(35):37895-905. doi: 10.18632/oncotarget.5634.
8
MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.由BRAF(V600E)突变而非基因扩增所支持的丝裂原活化蛋白激酶活性与黑色素瘤脑转移中的ETV1表达相关。
Arch Dermatol Res. 2014 Dec;306(10):873-84. doi: 10.1007/s00403-014-1490-6. Epub 2014 Jul 30.
9
BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.BRAF(V600)突变水平可预测转移性黑色素瘤对维莫非尼的反应。
Melanoma Res. 2014 Aug;24(4):415-8. doi: 10.1097/CMR.0000000000000088.
10
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.BRAF突变状态是切除的IIIB期和IIIC期黑色素瘤的独立预后因素:对黑色素瘤分期及辅助治疗的意义。
Eur J Cancer. 2014 Oct;50(15):2668-76. doi: 10.1016/j.ejca.2014.06.009. Epub 2014 Jul 25.